GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Other Current Receivables

Voluntis (XPAR:ALVTX) Other Current Receivables : €0.00 Mil (As of Jun. 2021)


View and export this data going back to 2018. Start your Free Trial

What is Voluntis Other Current Receivables?

Voluntis's Other Current Receivables for the quarter that ended in Jun. 2021 was €0.00 Mil.


Voluntis Other Current Receivables Historical Data

The historical data trend for Voluntis's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voluntis Other Current Receivables Chart

Voluntis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Other Current Receivables
- - - - -

Voluntis Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Voluntis Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Voluntis Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Voluntis's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Voluntis (XPAR:ALVTX) Business Description

Traded in Other Exchanges
N/A
Address
58, Avenue de Wagram, Paris, FRA, 75017
Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.

Voluntis (XPAR:ALVTX) Headlines

No Headlines